cholinergic receptor, muscarinic 3 |
MEPAZINE |
Muscarinic M3 |
98% |
.191uM |
.04uM |
View
|
5-hydroxytryptamine (serotonin) receptor 2C |
METHYSERGIDE |
Serotonin 5-HT2C |
98% |
.002087uM |
.001093uM |
View
|
Protein-tyrosine kinase, Fyn |
LEVODOPA |
Protein Tyrosine Kinase, Fyn |
98% |
2.146uM |
NoneNone |
View
|
histamine receptor H 1 |
RISPERIDONE |
Histamine H1, Central |
98% |
.025uM |
.00287uM |
View
|
cholinergic receptor, muscarinic 2 |
QUINACRINE |
Muscarinic M2 |
98% |
.964uM |
.343uM |
View
|
melanocortin 5 receptor |
L-744832 |
Melanocortin MC5 |
98% |
.122uM |
.114uM |
View
|
Protein-tyrosine kinase, Fyn |
L-744832 |
Protein Tyrosine Kinase, Fyn |
98% |
.813uM |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 2B |
KETOTIFEN |
Serotonin 5-HT2B |
98% |
.046uM |
.029uM |
View
|
cholinergic receptor, muscarinic 1 |
QUINACRINE |
Muscarinic M1 |
98% |
1.489uM |
.359uM |
View
|
5-hydroxytryptamine (serotonin) receptor 2C |
KETOTIFEN |
Serotonin 5-HT2C |
98% |
.16uM |
.084uM |
View
|
nuclear receptor subfamily 3, group C, member 1 |
NORGESTREL |
Glucocorticoid |
98% |
.149uM |
.068uM |
View
|
cholinergic receptor, muscarinic 5 |
NORTRIPTYLINE |
Muscarinic M5 |
98% |
.027uM |
.02uM |
View
|
5-hydroxytryptamine (serotonin) receptor 2B |
NORTRIPTYLINE |
Serotonin 5-HT2B |
98% |
.136uM |
.086uM |
View
|
5-hydroxytryptamine receptor 6 |
NORTRIPTYLINE |
Serotonin 5-HT6 |
98% |
.554uM |
.257uM |
View
|
adrenergic receptor, alpha 1a |
NORTRIPTYLINE |
Adrenergic alpha1A |
98% |
.305uM |
.123uM |
View
|
calcium channel, voltage-dependent, gamma subunit 8 |
NIMODIPINE |
Calcium Channel Type L, Dihydropyridine |
98% |
.000242uM |
.000156uM |
View
|
calcium channel, voltage-dependent, gamma subunit 7 |
NIMODIPINE |
Calcium Channel Type L, Dihydropyridine |
98% |
.000242uM |
.000156uM |
View
|
calcium channel, voltage-dependent, gamma subunit 6 |
NIMODIPINE |
Calcium Channel Type L, Dihydropyridine |
98% |
.000242uM |
.000156uM |
View
|
calcium channel, voltage-dependent, gamma subunit 5 |
NIMODIPINE |
Calcium Channel Type L, Dihydropyridine |
98% |
.000242uM |
.000156uM |
View
|
calcium channel, voltage-dependent, gamma subunit 4 |
NIMODIPINE |
Calcium Channel Type L, Dihydropyridine |
98% |
.000242uM |
.000156uM |
View
|
calcium channel, voltage-dependent, gamma subunit 3 |
NIMODIPINE |
Calcium Channel Type L, Dihydropyridine |
98% |
.000242uM |
.000156uM |
View
|
calcium channel, voltage-dependent, gamma subunit 2 |
NIMODIPINE |
Calcium Channel Type L, Dihydropyridine |
98% |
.000242uM |
.000156uM |
View
|
calcium channel, voltage-dependent, gamma subunit 1 |
NIMODIPINE |
Calcium Channel Type L, Dihydropyridine |
98% |
.000242uM |
.000156uM |
View
|
calcium channel, voltage-dependent, beta 4 subunit |
NIMODIPINE |
Calcium Channel Type L, Dihydropyridine |
98% |
.000242uM |
.000156uM |
View
|
calcium channel, voltage-dependent, beta 3 subunit |
NIMODIPINE |
Calcium Channel Type L, Dihydropyridine |
98% |
.000242uM |
.000156uM |
View
|
sodium channel associated protein 1 |
NIFEDIPINE |
Sodium Channel, Site 2 |
98% |
3.779uM |
3.388uM |
View
|
sodium channel associated protein 2 |
NIFEDIPINE |
Sodium Channel, Site 2 |
98% |
3.779uM |
3.388uM |
View
|
sodium channel, voltage-gated, type III, beta |
NIFEDIPINE |
Sodium Channel, Site 2 |
98% |
3.779uM |
3.388uM |
View
|
protein kinase C, zeta |
PACLITAXEL |
Phorbol Ester |
19% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type I, alpha |
NIFEDIPINE |
Sodium Channel, Site 2 |
98% |
3.779uM |
3.388uM |
View
|
sodium channel, voltage-gated, type IX, alpha |
NIFEDIPINE |
Sodium Channel, Site 2 |
98% |
3.779uM |
3.388uM |
View
|
sodium channel, voltage-gated, type VII, alpha |
NIFEDIPINE |
Sodium Channel, Site 2 |
98% |
3.779uM |
3.388uM |
View
|
amiloride-sensitive cation channel 5, intestinal |
NIFEDIPINE |
Sodium Channel, Site 2 |
98% |
3.779uM |
3.388uM |
View
|
5-hydroxytryptamine (serotonin) receptor 2C |
CLEMASTINE |
Serotonin 5-HT2C |
98% |
.099uM |
.052uM |
View
|
histamine receptor H 1 |
CLEMASTINE |
Histamine H1, Central |
98% |
.000421uM |
.000049uM |
View
|
5-hydroxytryptamine (serotonin) receptor 2B |
CLEMASTINE |
Serotonin 5-HT2B |
98% |
.036uM |
.023uM |
View
|
adrenergic receptor, alpha 1a |
CLOMIPRAMINE |
Adrenergic alpha1A |
98% |
.099uM |
.04uM |
View
|
cholinergic receptor, muscarinic 2 |
CLOMIPRAMINE |
Muscarinic M2 |
98% |
.241uM |
.086uM |
View
|
5-hydroxytryptamine (serotonin) receptor 1A |
CLOZAPINE |
Serotonin 5-HT1A |
98% |
.491uM |
.281uM |
View
|
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 |
CARVEDILOL |
Serotonin Transporter |
98% |
.221uM |
.118uM |
View
|
adrenergic receptor, beta 1 |
CARVEDILOL |
Adrenergic beta1 |
98% |
.000178uM |
.000103uM |
View
|
adrenergic, beta-1-, receptor |
CARVEDILOL |
Adrenergic beta1 |
98% |
.000178uM |
.000103uM |
View
|
adrenergic receptor, alpha 2a |
CLOZAPINE |
Adrenergic alpha2A |
98% |
.09uM |
.034uM |
View
|
androgen receptor |
OXYMETHOLONE |
Testosterone |
98% |
.206uM |
.137uM |
View
|
nuclear receptor subfamily 3, group C, member 1 |
DESOXIMETASONE |
Glucocorticoid |
98% |
.002573uM |
.001169uM |
View
|
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 4 |
DIPYRIDAMOLE |
GABAA, Benzodiazepine, Central |
98% |
.382uM |
.311uM |
View
|
gamma-aminobutyric acid A receptor, gamma 1 |
DIPYRIDAMOLE |
GABAA, Benzodiazepine, Central |
98% |
.382uM |
.311uM |
View
|
gamma-aminobutyric acid A receptor, pi |
DIPYRIDAMOLE |
GABAA, Benzodiazepine, Central |
98% |
.382uM |
.311uM |
View
|
AT hook, DNA binding motif, containing 1 (DBSS) |
DIPYRIDAMOLE |
GABAA, Benzodiazepine, Central |
98% |
.382uM |
.311uM |
View
|
gamma-aminobutyric acid A receptor, theta |
DIPYRIDAMOLE |
GABAA, Benzodiazepine, Central |
98% |
.382uM |
.311uM |
View
|
gamma-aminobutyric acid A receptor, gamma 2 |
DIPYRIDAMOLE |
GABAA, Benzodiazepine, Central |
98% |
.382uM |
.311uM |
View
|
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 6 |
DIPYRIDAMOLE |
GABAA, Benzodiazepine, Central |
98% |
.382uM |
.311uM |
View
|
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 5 |
DIPYRIDAMOLE |
GABAA, Benzodiazepine, Central |
98% |
.382uM |
.311uM |
View
|
gamma-aminobutyric acid A receptor, alpha 2 |
DIPYRIDAMOLE |
GABAA, Benzodiazepine, Central |
98% |
.382uM |
.311uM |
View
|
gamma-aminobutyric acid A receptor, alpha 1 |
DIPYRIDAMOLE |
GABAA, Benzodiazepine, Central |
98% |
.382uM |
.311uM |
View
|
gamma-aminobutyric acid (GABA-C) receptor, subunit rho 2 |
DIPYRIDAMOLE |
GABAA, Benzodiazepine, Central |
98% |
.382uM |
.311uM |
View
|
gamma-aminobutyric acid (GABA-C) receptor, subunit rho 1 |
DIPYRIDAMOLE |
GABAA, Benzodiazepine, Central |
98% |
.382uM |
.311uM |
View
|
gamma-aminobutyric acid A receptor, delta |
DIPYRIDAMOLE |
GABAA, Benzodiazepine, Central |
98% |
.382uM |
.311uM |
View
|
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 3 |
DIPYRIDAMOLE |
GABAA, Benzodiazepine, Central |
98% |
.382uM |
.311uM |
View
|
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 |
FLUOXETINE |
Serotonin Transporter |
98% |
.00051uM |
.000271uM |
View
|
5-hydroxytryptamine (serotonin) receptor 2B |
FLUPHENAZINE |
Serotonin 5-HT2B |
98% |
.039uM |
.025uM |
View
|
cholinergic receptor, muscarinic 2 |
DOXEPIN |
Muscarinic M2 |
98% |
.258uM |
.092uM |
View
|
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 |
DOXEPIN |
Serotonin Transporter |
98% |
.042uM |
.022uM |
View
|
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 4 |
DIAZEPAM |
GABAA, Benzodiazepine, Central |
98% |
.0288uM |
.0235uM |
View
|
gamma-aminobutyric acid A receptor, gamma 1 |
DIAZEPAM |
GABAA, Benzodiazepine, Central |
98% |
.0288uM |
.0235uM |
View
|
gamma-aminobutyric acid A receptor, pi |
DIAZEPAM |
GABAA, Benzodiazepine, Central |
98% |
.0288uM |
.0235uM |
View
|
AT hook, DNA binding motif, containing 1 (DBSS) |
DIAZEPAM |
GABAA, Benzodiazepine, Central |
98% |
.0288uM |
.0235uM |
View
|
gamma-aminobutyric acid A receptor, theta |
DIAZEPAM |
GABAA, Benzodiazepine, Central |
98% |
.0288uM |
.0235uM |
View
|
gamma-aminobutyric acid A receptor, gamma 2 |
DIAZEPAM |
GABAA, Benzodiazepine, Central |
98% |
.0288uM |
.0235uM |
View
|
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 6 |
DIAZEPAM |
GABAA, Benzodiazepine, Central |
98% |
.0288uM |
.0235uM |
View
|
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 5 |
DIAZEPAM |
GABAA, Benzodiazepine, Central |
98% |
.0288uM |
.0235uM |
View
|
gamma-aminobutyric acid A receptor, alpha 2 |
DIAZEPAM |
GABAA, Benzodiazepine, Central |
98% |
.0288uM |
.0235uM |
View
|
nuclear receptor subfamily 3, group C, member 1 |
HYDROCORTISONE |
Glucocorticoid |
98% |
.026uM |
.012uM |
View
|
adrenergic receptor, alpha 1d (Non-specific probe) |
DIHYDROERGOTAMINE |
Adrenergic alpha1D |
98% |
.029uM |
.014uM |
View
|
adrenergic receptor, alpha 2b |
TAMOXIFEN |
Adrenergic alpha2B |
98% |
3.518uM |
1.606uM |
View
|
5-hydroxytryptamine (serotonin) receptor 2A |
DICYCLOMINE |
Serotonin 5-HT2A |
98% |
.24uM |
.069uM |
View
|
sodium channel, voltage-gated, type III, beta |
NIFEDIPINE |
Sodium Channel, Site 2 |
98% |
3.779uM |
3.388uM |
View
|
sodium channel, voltage-gated, type VIII, alpha polypeptide |
NIFEDIPINE |
Sodium Channel, Site 2 |
98% |
3.779uM |
3.388uM |
View
|
sodium channel, voltage-gated, type XI, alpha |
NIFEDIPINE |
Sodium Channel, Site 2 |
98% |
3.779uM |
3.388uM |
View
|
sodium channel, voltage-gated, type I, beta |
NIFEDIPINE |
Sodium Channel, Site 2 |
98% |
3.779uM |
3.388uM |
View
|
sodium channel, voltage-gated, type 10, alpha polypeptide |
NIFEDIPINE |
Sodium Channel, Site 2 |
98% |
3.779uM |
3.388uM |
View
|
sodium channel, voltage-gated, type IV, alpha polypeptide |
NIFEDIPINE |
Sodium Channel, Site 2 |
98% |
3.779uM |
3.388uM |
View
|
sodium channel, voltage-gated, type V, alpha polypeptide |
NIFEDIPINE |
Sodium Channel, Site 2 |
98% |
3.779uM |
3.388uM |
View
|
sodium channel, voltage-gated, type II, beta |
NIFEDIPINE |
Sodium Channel, Site 2 |
98% |
3.779uM |
3.388uM |
View
|
sodium channel, nonvoltage-gated 1 alpha |
NIFEDIPINE |
Sodium Channel, Site 2 |
98% |
3.779uM |
3.388uM |
View
|
sodium channel, nonvoltage-gated 1 gamma |
NIFEDIPINE |
Sodium Channel, Site 2 |
98% |
3.779uM |
3.388uM |
View
|
sodium channel, nonvoltage-gated 1 beta |
NIFEDIPINE |
Sodium Channel, Site 2 |
98% |
3.779uM |
3.388uM |
View
|
sodium channel, voltage-gated, type 2, alpha 1 polypeptide |
NIFEDIPINE |
Sodium Channel, Site 2 |
98% |
3.779uM |
3.388uM |
View
|
sodium channel, voltage-gated, type XI, alpha |
NIFEDIPINE |
Sodium Channel, Site 2 |
98% |
3.779uM |
3.388uM |
View
|
sodium channel, nonvoltage-gated 1, gamma |
NIFEDIPINE |
Sodium Channel, Site 2 |
98% |
3.779uM |
3.388uM |
View
|
sodium channel, nonvoltage-gated 1, delta |
NIFEDIPINE |
Sodium Channel, Site 2 |
98% |
3.779uM |
3.388uM |
View
|
sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) |
NIFEDIPINE |
Sodium Channel, Site 2 |
98% |
3.779uM |
3.388uM |
View
|
sodium channel, nonvoltage-gated 1 alpha |
NIFEDIPINE |
Sodium Channel, Site 2 |
98% |
3.779uM |
3.388uM |
View
|
sodium channel, voltage-gated, type X, alpha |
NIFEDIPINE |
Sodium Channel, Site 2 |
98% |
3.779uM |
3.388uM |
View
|
sodium channel, voltage-gated, type IX, alpha |
NIFEDIPINE |
Sodium Channel, Site 2 |
98% |
3.779uM |
3.388uM |
View
|
sodium channel, voltage gated, type VIII, alpha |
NIFEDIPINE |
Sodium Channel, Site 2 |
98% |
3.779uM |
3.388uM |
View
|
sodium channel, voltage-gated, type VII, alpha |
NIFEDIPINE |
Sodium Channel, Site 2 |
98% |
3.779uM |
3.388uM |
View
|
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) |
NIFEDIPINE |
Sodium Channel, Site 2 |
98% |
3.779uM |
3.388uM |
View
|
sodium channel, voltage-gated, type IV, beta |
NIFEDIPINE |
Sodium Channel, Site 2 |
98% |
3.779uM |
3.388uM |
View
|
sodium channel, voltage-gated, type IV, alpha |
NIFEDIPINE |
Sodium Channel, Site 2 |
98% |
3.779uM |
3.388uM |
View
|
sodium channel, voltage-gated, type III, alpha |
NIFEDIPINE |
Sodium Channel, Site 2 |
98% |
3.779uM |
3.388uM |
View
|
sodium channel, voltage-gated, type II, beta |
NIFEDIPINE |
Sodium Channel, Site 2 |
98% |
3.779uM |
3.388uM |
View
|
sodium channel, voltage-gated, type II, alpha 2 |
NIFEDIPINE |
Sodium Channel, Site 2 |
98% |
3.779uM |
3.388uM |
View
|
sodium channel, voltage-gated, type I, beta |
NIFEDIPINE |
Sodium Channel, Site 2 |
98% |
3.779uM |
3.388uM |
View
|
sodium channel, voltage-gated, type I, alpha |
NIFEDIPINE |
Sodium Channel, Site 2 |
98% |
3.779uM |
3.388uM |
View
|
sodium channel, voltage-gated, type IV, beta |
NIFEDIPINE |
Sodium Channel, Site 2 |
98% |
3.779uM |
3.388uM |
View
|
3-hydroxy-3-methylglutaryl-Coenzyme A reductase |
MEVASTATIN |
HMG-CoA Reductase |
98% |
.119uM |
NoneNone |
View
|
cytochrome P450, family 3, subfamily a, polypeptide 13 |
SULCONAZOLE |
CYP450-3A4 Inhibition |
98% |
.07uM |
NoneNone |
View
|
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 |
SULCONAZOLE |
Serotonin Transporter |
98% |
.141uM |
.075uM |
View
|
cholinergic receptor, muscarinic 3 |
DIETHYLSTILBESTROL |
Muscarinic M3 |
98% |
18.432uM |
3.907uM |
View
|
adrenergic receptor, alpha 2b |
DIETHYLSTILBESTROL |
Adrenergic alpha2B |
98% |
11.698uM |
5.34uM |
View
|
opioid receptor, kappa 1 |
DIETHYLSTILBESTROL |
Opiate kappa |
98% |
4.563uM |
1.825uM |
View
|
androgen receptor |
BETA-ESTRADIOL |
Testosterone |
98% |
.353uM |
.235uM |
View
|
A3 adenosine receptor |
4-OCTYLPHENOL |
Adenosine A3 |
98% |
6.014uM |
3.399uM |
View
|
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 |
4-OCTYLPHENOL |
Serotonin Transporter |
98% |
6.973uM |
3.704uM |
View
|
nuclear receptor subfamily 3, group C, member 1 |
BETAMETHASONE |
Glucocorticoid |
98% |
.007735uM |
.003516uM |
View
|
nuclear receptor subfamily 3, group C, member 1 |
TRIAMCINOLONE |
Glucocorticoid |
98% |
.058uM |
.026uM |
View
|
protein kinase C, gamma |
PACLITAXEL |
Phorbol Ester |
19% |
NoneNone |
NoneNone |
View
|
tachykinin receptor 2 |
ALPHA-NAPHTHOFLAVONE |
Tachykinin NK2 |
98% |
5.8471uM |
1.949uM |
View
|
Protein-tyrosine kinase, Fyn |
DOXORUBICIN |
Protein Tyrosine Kinase, Fyn |
98% |
5.147uM |
NoneNone |
View
|
cholinergic receptor, muscarinic 4 |
AMITRIPTYLINE |
Muscarinic M4 |
98% |
.005297uM |
.000739uM |
View
|
monoamine oxidase A |
2-HYDROXYPROPYL-BETA-CYCLODEXTRIN |
Monoamine Oxidase MAOA |
98% |
.167uM |
NoneNone |
View
|
monoamine oxidase A |
2-HYDROXYPROPYL-BETA-CYCLODEXTRIN |
Monoamine Oxidase MAOA |
98% |
.167uM |
NoneNone |
View
|
cholinergic receptor, muscarinic 2 |
AMITRIPTYLINE |
Muscarinic M2 |
98% |
.081uM |
.029uM |
View
|
5-hydroxytryptamine (serotonin) receptor 2C |
AMOXAPINE |
Serotonin 5-HT2C |
98% |
.003787uM |
.001984uM |
View
|
dopamine receptor D1A |
AMOXAPINE |
Dopamine D1 |
98% |
.392uM |
.196uM |
View
|
cholinergic receptor, muscarinic 3 |
AMITRIPTYLINE |
Muscarinic M3 |
98% |
.026uM |
.005436uM |
View
|
dopamine receptor D1A |
CLOTRIMAZOLE |
Dopamine D1 |
98% |
9.017uM |
4.508uM |
View
|
gamma-aminobutyric acid A receptor, alpha 1 |
DIAZEPAM |
GABAA, Benzodiazepine, Central |
98% |
.0288uM |
.0235uM |
View
|
gamma-aminobutyric acid (GABA-C) receptor, subunit rho 2 |
DIAZEPAM |
GABAA, Benzodiazepine, Central |
98% |
.0288uM |
.0235uM |
View
|
gamma-aminobutyric acid (GABA-C) receptor, subunit rho 1 |
DIAZEPAM |
GABAA, Benzodiazepine, Central |
98% |
.0288uM |
.0235uM |
View
|
gamma-aminobutyric acid A receptor, delta |
DIAZEPAM |
GABAA, Benzodiazepine, Central |
98% |
.0288uM |
.0235uM |
View
|
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 3 |
DIAZEPAM |
GABAA, Benzodiazepine, Central |
98% |
.0288uM |
.0235uM |
View
|
cholinergic receptor, muscarinic 5 |
DOXEPIN |
Muscarinic M5 |
98% |
.026uM |
.019uM |
View
|
prostaglandin-endoperoxide synthase 1 |
MEFENAMIC ACID |
Cyclooxygenase COX-1 |
98% |
.116uM |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) |
MEFENAMIC ACID |
Cyclooxygenase COX-1 |
98% |
.116uM |
NoneNone |
View
|
adrenergic receptor, alpha 1a |
LABETALOL |
Adrenergic alpha1A |
98% |
.057uM |
.023uM |
View
|
Sigma-2 Receptor |
HALOPERIDOL |
Sigma2 |
98% |
.058uM |
.036uM |
View
|
5-hydroxytryptamine (serotonin) receptor 2B |
TRAZODONE |
Serotonin 5-HT2B |
98% |
.107uM |
.068uM |
View
|
adrenergic receptor, alpha 2b |
GENTIAN VIOLET |
Adrenergic alpha2C |
98% |
1.884uM |
.274uM |
View
|
adrenergic receptor, alpha 2c (Non-specific probe) |
GENTIAN VIOLET |
Adrenergic alpha2C |
98% |
1.884uM |
.274uM |
View
|
5-hydroxytryptamine (serotonin) receptor 3a |
GRANISETRON |
Serotonin 5-HT3 |
98% |
.003391uM |
.000762uM |
View
|
5-hydroxytryptamine (serotonin) receptor 3b |
GRANISETRON |
Serotonin 5-HT3 |
98% |
.003391uM |
.000762uM |
View
|
cholinergic receptor, muscarinic 5 |
GENTIAN VIOLET |
Muscarinic M5 |
98% |
.535uM |
.384uM |
View
|
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 4 |
NITRAZEPAM |
GABAA, Benzodiazepine, Central |
98% |
.0547uM |
.0446uM |
View
|
gamma-aminobutyric acid A receptor, gamma 1 |
NITRAZEPAM |
GABAA, Benzodiazepine, Central |
98% |
.0547uM |
.0446uM |
View
|
sodium channel, voltage-gated, type I, alpha |
CLOTRIMAZOLE |
Sodium Channel, Site 2 |
98% |
6.771uM |
6.071uM |
View
|
calcium channel, voltage-dependent, gamma subunit 8 |
CHLORPROMAZINE |
Calcium Channel Type L, Phenylalkylamine |
98% |
1.527uM |
1.485uM |
View
|
calcium channel, voltage-dependent, gamma subunit 7 |
CHLORPROMAZINE |
Calcium Channel Type L, Phenylalkylamine |
98% |
1.527uM |
1.485uM |
View
|
calcium channel, voltage-dependent, gamma subunit 6 |
CHLORPROMAZINE |
Calcium Channel Type L, Phenylalkylamine |
98% |
1.527uM |
1.485uM |
View
|
calcium channel, voltage-dependent, gamma subunit 5 |
CHLORPROMAZINE |
Calcium Channel Type L, Phenylalkylamine |
98% |
1.527uM |
1.485uM |
View
|
calcium channel, voltage-dependent, gamma subunit 4 |
CHLORPROMAZINE |
Calcium Channel Type L, Phenylalkylamine |
98% |
1.527uM |
1.485uM |
View
|
calcium channel, voltage-dependent, gamma subunit 3 |
CHLORPROMAZINE |
Calcium Channel Type L, Phenylalkylamine |
98% |
1.527uM |
1.485uM |
View
|
calcium channel, voltage-dependent, gamma subunit 2 |
CHLORPROMAZINE |
Calcium Channel Type L, Phenylalkylamine |
98% |
1.527uM |
1.485uM |
View
|
calcium channel, voltage-dependent, gamma subunit 1 |
CHLORPROMAZINE |
Calcium Channel Type L, Phenylalkylamine |
98% |
1.527uM |
1.485uM |
View
|
calcium channel, voltage-dependent, beta 4 subunit |
CHLORPROMAZINE |
Calcium Channel Type L, Phenylalkylamine |
98% |
1.527uM |
1.485uM |
View
|
calcium channel, voltage-dependent, beta 3 subunit |
CHLORPROMAZINE |
Calcium Channel Type L, Phenylalkylamine |
98% |
1.527uM |
1.485uM |
View
|
calcium channel, voltage-dependent, beta 2 subunit |
CHLORPROMAZINE |
Calcium Channel Type L, Phenylalkylamine |
98% |
1.527uM |
1.485uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1S subunit |
CHLORPROMAZINE |
Calcium Channel Type L, Phenylalkylamine |
98% |
1.527uM |
1.485uM |
View
|
calcium channel, voltage-dependent, alpha 1F subunit |
CHLORPROMAZINE |
Calcium Channel Type L, Phenylalkylamine |
98% |
1.527uM |
1.485uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1D subunit |
CHLORPROMAZINE |
Calcium Channel Type L, Phenylalkylamine |
98% |
1.527uM |
1.485uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1C subunit |
CHLORPROMAZINE |
Calcium Channel Type L, Phenylalkylamine |
98% |
1.527uM |
1.485uM |
View
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
CHLORPROMAZINE |
Calcium Channel Type L, Phenylalkylamine |
98% |
1.527uM |
1.485uM |
View
|
calcium channel, voltage-dependent, beta 1 subunit |
CHLORPROMAZINE |
Calcium Channel Type L, Phenylalkylamine |
98% |
1.527uM |
1.485uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1E subunit |
CHLORPROMAZINE |
Calcium Channel Type L, Phenylalkylamine |
98% |
1.527uM |
1.485uM |
View
|
calcium channel, voltage-dependent, N type, alpha 1B subunit |
CHLORPROMAZINE |
Calcium Channel Type L, Phenylalkylamine |
98% |
1.527uM |
1.485uM |
View
|
calcium channel, voltage-dependent, alpha2/delta subunit 1 |
CHLORPROMAZINE |
Calcium Channel Type L, Phenylalkylamine |
98% |
1.527uM |
1.485uM |
View
|
cholinergic receptor, muscarinic 1 |
CHLORPROMAZINE |
Muscarinic M1 |
98% |
.083uM |
.02uM |
View
|
cholinergic receptor, muscarinic 3 |
CHLORPROMAZINE |
Muscarinic M3 |
98% |
.206uM |
.044uM |
View
|
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 |
CHLORPROMAZINE |
Serotonin Transporter |
98% |
.039uM |
.021uM |
View
|
cholinergic receptor, muscarinic 2 |
TROPICAMIDE |
Muscarinic M2 |
98% |
.105uM |
.037uM |
View
|
adrenergic receptor, alpha 2a |
YOHIMBINE |
Adrenergic alpha2A |
98% |
.006151uM |
.002307uM |
View
|
5-hydroxytryptamine (serotonin) receptor 2A |
TAMOXIFEN |
Serotonin 5-HT2A |
98% |
4.801uM |
1.372uM |
View
|
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) |
TAMOXIFEN |
Protein Tyrosine Kinase, HER2 Receptor |
98% |
2.949uM |
NoneNone |
View
|
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) |
TAMOXIFEN |
Protein Tyrosine Kinase, HER2 Receptor |
98% |
2.949uM |
NoneNone |
View
|
5-hydroxytryptamine receptor 6 |
TAMOXIFEN |
Serotonin 5-HT6 |
98% |
2.679uM |
1.244uM |
View
|
adrenergic receptor, alpha 1b |
CYPROHEPTADINE |
Adrenergic alpha1B |
99% |
.08uM |
.044uM |
View
|
5-hydroxytryptamine (serotonin) receptor 3a |
ALOSETRON |
Serotonin 5-HT3 |
99% |
.001164uM |
.000262uM |
View
|
5-hydroxytryptamine (serotonin) receptor 3b |
ALOSETRON |
Serotonin 5-HT3 |
99% |
.001164uM |
.000262uM |
View
|
cholinergic receptor, muscarinic 2 |
MICONAZOLE |
Muscarinic M2 |
99% |
4.336uM |
1.542uM |
View
|
dopamine receptor 2 |
ECONAZOLE |
Dopamine D2L |
99% |
12.807uM |
4.269uM |
View
|
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) |
ECONAZOLE |
Protein Tyrosine Kinase, HER2 Receptor |
99% |
13.904uM |
NoneNone |
View
|
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) |
ECONAZOLE |
Protein Tyrosine Kinase, HER2 Receptor |
99% |
13.904uM |
NoneNone |
View
|
cholinergic receptor, muscarinic 2 |
ECONAZOLE |
Muscarinic M2 |
99% |
3.256uM |
1.158uM |
View
|
5-hydroxytryptamine (serotonin) receptor 2A |
ECONAZOLE |
Serotonin 5-HT2A |
99% |
4.034uM |
1.152uM |
View
|
cholinergic receptor, muscarinic 3 |
CIGLITAZONE |
Muscarinic M3 |
99% |
14.947uM |
3.168uM |
View
|
5-hydroxytryptamine (serotonin) receptor 2A |
ERGOCORNINE |
Serotonin 5-HT2A |
99% |
.028uM |
.007995uM |
View
|
progesterone receptor |
BUDESONIDE |
Progesterone |
99% |
.21uM |
.027uM |
View
|
progesterone receptor |
BUDESONIDE |
Progesterone |
99% |
.21uM |
.027uM |
View
|
adrenergic receptor, alpha 2a |
AURANOFIN |
Adrenergic alpha2A |
99% |
.884uM |
.331uM |
View
|
nuclear receptor subfamily 3, group C, member 1 |
BECLOMETHASONE |
Glucocorticoid |
99% |
.008234uM |
.003743uM |
View
|
nuclear receptor subfamily 3, group C, member 1 |
MEDROXYPROGESTERONE |
Glucocorticoid |
99% |
.019uM |
.008597uM |
View
|
5-hydroxytryptamine (serotonin) receptor 2B |
CAMPTOTHECIN |
Serotonin 5-HT2B |
99% |
.97uM |
.617uM |
View
|
A3 adenosine receptor |
SULCONAZOLE |
Adenosine A3 |
99% |
2.628uM |
1.485uM |
View
|
arachidonate 15-lipoxygenase, second type |
MIFEPRISTONE |
Lipoxygenase 15-LO |
99% |
.555uM |
NoneNone |
View
|
arachidonate 15-lipoxygenase |
MIFEPRISTONE |
Lipoxygenase 15-LO |
99% |
.555uM |
NoneNone |
View
|
arachidonate 15-lipoxygenase |
MIFEPRISTONE |
Lipoxygenase 15-LO |
99% |
.555uM |
NoneNone |
View
|
potassium voltage-gated channel, subfamily H, member 8 |
HALOPERIDOL |
Potassium Channel HERG |
99% |
NoneNone |
NoneNone |
View
|
potassium voltage-gated channel, subfamily H (eag-related), member 6 |
HALOPERIDOL |
Potassium Channel HERG |
99% |
NoneNone |
NoneNone |
View
|
potassium voltage-gated channel, subfamily H (eag-related), member 7 |
HALOPERIDOL |
Potassium Channel HERG |
99% |
NoneNone |
NoneNone |
View
|